Revisiting Heterochromatin in Embryonic Stem Cells


article has not abstract


Published in the journal: . PLoS Genet 7(6): e32767. doi:10.1371/journal.pgen.1002093
Category: Perspective
doi: 10.1371/journal.pgen.1002093

Summary

article has not abstract

It is widely believed that chromatin in embryonic stem (ES) cells exists in a unique “open” conformation, characterized by sparse, disorganized heterochromatin and prevalent global transcription. Upon differentiation, this “blueprint” of pluripotent state is thought to undergo dramatic remodelling. In this issue of PLoS Genetics, Lienert and colleagues [1] revisit heterochromatin and transcription in pluripotent and terminally differentiated cells to demonstrate that neither the abundance of repressive histone H3 lysine 9 dimethylation (H3K9me2) nor the net transcriptional output of the genome discriminate these two very different cell states.

Pluripotent ES cells, derived from the inner cell mass of developing mammalian blastocyst, have the distinctive ability to self-renew in culture and differentiate into multiple lineages when exposed to appropriate signals. The self-organizing regulatory network of transcription factors and the epigenetic mechanisms that are involved in maintenance of pluripotent state and self-renewal are actively debated and intensively studied by many laboratories [2], [3]. When induced to differentiate, ES cells respond by changes in gene expression, cell morphology, and chromatin structure, which may collectively contribute to a reduction in developmental plasticity [4], [5].

Several lines of evidence have suggested that DNA in stem cells is packaged into an unusually dynamic form of chromatin that carries ES cell–specific patterns of histone modifications. Thus, in ES cells, histone H3 and H4 tend to be hyperacetylated; constitutive heterochromatin foci, marked by histone H3 lysine 9 trimethylation (H3K9me3), are fewer and less well organized; and histone and non-histone chromatin-bound proteins, such as heterochromatin protein 1 (HP1), are more mobile [4], [6], [7]. In addition, a substantial number of gene promoters in ES cells is marked by closely juxtaposed active (H3K4me3) and repressive (H3K27me3) chromatin modifications [8], [9]. This so-called bivalent or poised chromatin is resolved into a monovalent state at most, but not all, loci upon differentiation [9], [10]. However, repressive chromatin marks come in several “flavours”. Of those, H3K9me2 is a relatively abundant modification associated with facultative heterochromatin that covers large, gene-poor regions of the genome [11]. It has been reported that these H9K9me2 domains are “minimally present” in ES cells, but undergo substantial expansion and stabilization in differentiated tissues, such as liver and brain, resulting in transcriptional silencing of genes residing in these domains [11], [12]. Further studies have found that chromatin regions marked by other repressive modifications, such as H3K9me3 and H3K27me3, are also larger in lineage-restricted human lung fibroblasts IMR90 when compared to human ES cells. These regions undergo remodelling and reduction in size upon reprogramming of IMR90 cells into induced pluripotent stem cells (iPSCs) [10]. Collectively, these observations suggest that lineage commitment and differentiation are accompanied by expansion and stabilization of repressive chromatin.

In order to investigate in detail the changes in H3K9me2-marked heterochromatin domains during terminal differentiation, Lienert et al. [1] used a robust in vitro neurogenesis system to differentiate ES cells into postmitotic pyramidal neurons [13]. Profiles of H3K9me2, representing ∼10% of the genome, including the entire chromosome 19, were generated for both cell types and compared to each other. Surprisingly, it was found that these profiles showed high degree of correlation between ES cells and neurons. In both cell types, H3K9me2 covered ∼50% of chromosome 19, and a very modest increase in H3K9me2 (5%) was observed in terminally differentiated neurons. In agreement with an earlier study [11], H3K9me2 was enriched at large chromosomal domains, but those were generally invariable in median size and distribution between ES cells and neurons, and mutually exclusive with active (H3K4me2) and other repressive chromatin marks (H3K27me3). Some discrete differences were observed; those included gain of H3K9me2 over new large domains in neurons, mostly over the bodies of transcribed genes, as well as loss of H3K9me2 from much smaller regions (Figure 1). Furthermore, high throughput sequencing of RNA (RNA-seq) from ES cells, neurons, and, additionally, mouse embryonic fibroblasts, showed well defined cell type–specific expression, but no significant overall difference in the transcribed portion of the genome, including most repetitive sequences. Although the findings of Lienert et al. [1] seem to disagree with previous studies [4], [11], these discrepancies could be largely explained by methodological differences in the analyses of H3K9me2 genomic microarray data [12] and the accuracy in discriminating between low and absent transcription by microarrays, which may suffer from crosshybridization, versus unambiguous direct counting of RNA sequence reads [1]. As both Effroni et al. [4] and Lienert et al. [1] have measured the abundance of polyadenylated RNAs, reflecting mostly the productive transcription, it might be interesting to employ global nuclear run-on coupled with high throughput sequencing (NRO-seq) [14] in order to explore whether the extent of non-productive transcription differs significantly between ES cells and terminally differentiated neurons.

Fig. 1.

In summary, the observations of Lienert et al. [1] highlight the remarkable conservation of the facultative heterochromatin domains and the global transcriptional output of the genome between ES cells and terminally differentiated neurons. They also suggest that genome reprogramming during lineage commitment and differentiation is largely achieved by developmental cues and strong transcription factors, which induce localized and highly specific changes in heterochromatin rather than promote genome-wide build up of H3K9me2 and suppression of global low-level transcription. Such a model is further supported by findings that differentiation of ES cells into neuronal progenitors and then into astrocytes is accompanied by focal, localized rearrangements in chromatin-nuclear lamina interactions, while the overall architecture of lamina-associated chromosomal domains remains largely preserved [15].

It cannot be completely ruled out that, although quantitatively similar, heterochromatin is qualitatively different, more fluid and, perhaps, less essential in ES cells than in terminally differentiated cells and tissues. Such plasticity could be mediated by chromatin remodelling ATPases, histone acetyltransferases, and histone demethylases, some of which are highly expressed in stem cells and essential for pluripotency [4], [16][18]. Is heterochromatin then functional in ES cells?

The vast majority of H3K9me2 in the genome is established by the euchromatic histone methylases EHMT2 and EHMT1, also known as G9a and GLP, respectively. Similar to the knockouts of DNA methyltransferases [19], ES cells lacking either G9a or GLP are viable and morphologically normal, but G9a−/− and Glp−/− embryos die in midgestation (E9–9.5) [20], [21]. This suggests that, although DNA methylation and G9a/GLP-dependent H3K9me2 are dispensable for self-renewal in ES cells, they become vital during differentiation and embryonic development. Unfortunately, the differentiation potential of G9a−/− and Glp−/− ES cells has never been investigated in detail. Nevertheless, these cells form embryonic bodies upon induction with retinoic acid, but fail to terminally silence OCT3/4 [22], indicating that G9a/GLP-dependent heterochromatin formation may safeguard rather than actively channel differentiation.

Despite the overwhelming evidence that heterochromatin is present, but somewhat “wimpy” in stem cells, it was reported that H3K9me2- and H3K9me3-specific histone demethylases JMJD1A and JMJD2C, respectively, are directly regulated by OCT3/4 transcription factor and are essential for maintenance of pluripotency [18]. Depletion of these enzymes by small interfering RNAs (siRNAs) leads to accumulation of H3K9me and unscheduled differentiation. However, it was also clearly shown that JMJD1A and JMJD2C action is restricted to specific loci and does not lead to ubiquitous removal of H3K9me from the genome. Taken together with the studies of Lienert et al. [1], these findings firmly indicate that heterochromatin is functional in ES cells and has to be actively remodelled in order to allow the self-organizing network of transcription factors to prevent differentiation and promote self-renewal. The same general principle of local heterochromatin removal by lineage-specific transcriptional regulators may operate during differentiation.


Zdroje

1. LienertFMohnFTiwariVKBaubecTRoloffTC

2011

Genomic prevalence of heterochromatic H3K9me2 and transcription

do not discriminate pluripotent from terminally differentiated

cells.

PLoS Genet

7

e100290

doi:10.1371/journal.pgen.1002090

2. HannaJHSahaKJaenischR

2010

Pluripotency and cellular reprogramming: facts, hypotheses,

unresolved issues.

Cell

143

508

525

3. YoungRA

2011

Control of the embryonic stem cell state.

Cell

144

940

954

4. EfroniSDuttaguptaRChengJDehghaniHHoeppnerDJ

2008

Global transcription in pluripotent embryonic stem

cells.

Cell Stem Cell

2

437

447

5. MeshorerEMisteliT

2006

Chromatin in pluripotent embryonic stem cells and

differentiation.

Nat Rev Mol Cell Biol

7

540

546

6. MeshorerEYellajoshulaDGeorgeEScamblerPJBrownDT

2006

Hyperdynamic plasticity of chromatin proteins in pluripotent

embryonic stem cells.

Dev Cell

10

105

116

7. KeohaneAMO'NeillLPBelyaevNDLavenderJSTurnerBM

1996

X-Inactivation and histone H4 acetylation in embryonic stem

cells.

Dev Biol

180

618

630

8. BernsteinBEMikkelsenTSXieXKamalMHuebertDJ

2006

A bivalent chromatin structure marks key developmental genes in

embryonic stem cells.

Cell

125

315

326

9. MeissnerAMikkelsenTSGuHWernigMHannaJ

2008

Genome-scale DNA methylation maps of pluripotent and

differentiated cells.

Nature

454

766

770

10. HawkinsRDHonGCLeeLKNgoQListerR

2010

Distinct epigenomic landscapes of pluripotent and

lineage-committed human cells.

Cell Stem Cell

6

479

491

11. WenBWuHShinkaiYIrizarryRAFeinbergAP

2009

Large histone H3 lysine 9 dimethylated chromatin blocks

distinguish differentiated from embryonic stem cells.

Nat Genet

41

246

250

12. FilionGJvan SteenselB

2010

Reassessing the abundance of H3K9me2 chromatin domains in

embryonic stem cells.

Nat Genet

42

4; author reply 5–6

13. BibelMRichterJSchrenkKTuckerKLStaigerV

2004

Differentiation of mouse embryonic stem cells into a defined

neuronal lineage.

Nat Neurosci

7

1003

1009

14. CoreLJWaterfallJJLisJT

2008

Nascent RNA sequencing reveals widespread pausing and divergent

initiation at human promoters.

Science

322

1845

1848

15. Peric-HupkesDMeulemanWPagieLBruggemanSWSoloveiI

2010

Molecular maps of the reorganization of genome-nuclear lamina

interactions during differentiation.

Mol Cell

38

603

613

16. NiwaH

2007

Open conformation chromatin and pluripotency.

Genes Dev

21

2671

2676

17. SchnetzMPHandokoLAkhtar-ZaidiBBartelsCFPereiraCF

2010

CHD7 targets active gene enhancer elements to modulate ES

cell-specific gene expression.

PLoS Genet

6

e1001023

doi:10.1371/journal.pgen.1001023

18. LohYHZhangWChenXGeorgeJNgHH

2007

Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate

self-renewal in embryonic stem cells.

Genes Dev

21

2545

2557

19. GollMGBestorTH

2005

Eukaryotic cytosine methyltransferases.

Annu Rev Biochem

74

481

514

20. TachibanaMSugimotoKNozakiMUedaJOhtaT

2002

G9a histone methyltransferase plays a dominant role in

euchromatic histone H3 lysine 9 methylation and is essential for early

embryogenesis.

Genes Dev

16

1779

1791

21. TachibanaMUedaJFukudaMTakedaNOhtaT

2005

Histone methyltransferases G9a and GLP form heteromeric complexes

and are both crucial for methylation of euchromatin at

H3-K9.

Genes Dev

19

815

826

22. FeldmanNGersonAFangJLiEZhangY

2006

G9a-mediated irreversible epigenetic inactivation of Oct-3/4

during early embryogenesis.

Nat Cell Biol

8

188

194

Štítky
Genetika Reprodukční medicína

Článek vyšel v časopise

PLOS Genetics


2011 Číslo 6

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Proč v prevenci zubního kazu kartáček nestačí?
nový kurz
Autoři: doc. MUDr. Romana Koberová – Ivančaková, CSc.

Hypersenzitivita dentinu jako příznak poškození tvrdých zubních tkání
Autoři: MUDr. Erika Lenčová, Ph.D.

Cesta pacienta s CHOPN
Autoři: doc. MUDr. Vladimír Koblížek, Ph.D.

Arteriální hypertenze ve světle nových evropských guidelines
Autoři: MUDr. Libor Jelínek

Precizní medicína v onkologii
Autoři:

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se